Proliferation Signal Inhibitors: Sirolimus and Everolimus.
- Author:
Joong Kyung KIM
1
Author Information
1. Department of Internal Medicine, BongSeng Hospital, Busan, Korea. kidney119@hotmail.com
- Publication Type:Review
- Keywords:
Renal transplantation;
Proliferation signal inhibitor;
Nephrotoxicity
- MeSH:
Allografts;
B-Lymphocytes;
Cell Cycle;
Cyclosporine;
Everolimus;
Kidney Transplantation;
Sirolimus*;
Tacrolimus
- From:The Journal of the Korean Society for Transplantation
2006;20(2):143-148
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Proliferation signal inhibitors are a new class of immunosuppressant. They inhibit the mammalian target of rapamycin and blocks the cell cycle of various cell types, including T and B lymphocytes. PSI is used in renal transplantation as a maintenance immunosuppressant. The benefit of this drug in some immunologic and malignant disease is currently under being focused. Reports of synergism with cyclosporine and tacrolimus in preclinical and clinical studies, avoidance of nephrotoxicity and possible treatment or prevention of chronic allograft nephropathy are leading to high expectations for this new class of immunosuppressant. This review summarizes preclinical and clinical results published to date and evaluates the future value of PSI for renal transplantation.
